Demonstration Formulary
4 Central nervous system
PALLIATIVE CARE PHYSICIANS - Guidelines for the use of drugs in symptom control
04-03-01 Tricyclic antidepressants
| Dosulepin |
|
Non Formulary
|
|
 Patient Information: Changes to dosulepin prescribing |
|
| Trimipramine |
|
Non Formulary
|
|
|
Patient Information: Changes to trimipramine prescribing |
|
|
Links
Administration of depot antipsychotic injections during COVID-19 in stable adult patients- NICE CG26: Post-traumatic stress disorder (PTSD)
- NICE CG28: Depression in children and young people
- NICE CG53: Chronic fatigue syndrome / Myalgic encephalomyelitis
- NICE CG61: Irritable Bowel Syndrome
- NICE CG90: Depression in adults (update)
- NICE CG91: Depression with a chronic physical health problem
- Patient Information: Changes to dosulepin prescribing
- Patient Information: Changes to trimipramine prescribing
UKMI Q&A: Can breastfeeding mothers take SSRI's?- UKMI Q&A: Epileptics - What is the most appropriate antidepressant to use?
- UKMI Q&A: Management of depression in breast feeding mothers - Are St.John’s Wort and other complementary therapies safe?
- UKMI Q&A: TCAs causing tinnitus?
- UKMI Q&A: What is the first choice antidepressant for patients with renal impairment?
- UKMI Q&A: What is the risk of interaction opioid analgesics and monoamine oxidase inhibitors (MAOIs)?
- UKMI Q&A; How do you switch between tricyclic, SSRI and related antidepressants?
- UKMI Q&A; Management of depression in breast feeding mothers - Are reboxetine, venlafaxine, mirtazepine and MAOIs safe?